Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, School of Medicine, Louisiana State University Health Sciences Center, Children's Hospital of New Orleans, New Orleans, LA, USA.
Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA.
J Diabetes Sci Technol. 2021 Sep;15(5):1069-1075. doi: 10.1177/19322968211021386. Epub 2021 Jun 17.
Achieving normal or near-normal glycemic control as reflected by HbA1c levels in patients with type 1 diabetes (T1D) is important for preventing the development and progression of chronic complications. Despite delineation and dissemination of HbA1c management targets and advances in insulin pharmacology, insulin delivery systems, and glucose monitoring, the majority of children with T1D do not achieve HbA1c goals. In particular, African Americans are more likely not to reach HbA1c goals and have persistently higher HbA1c than Non-Hispanic Whites. Availability of pumps and other technology has not eliminated the disparity in HbA1c. Multiple factors play a role in the persisting racial disparity in HbA1c outcome. The carefully designed application and deployment of new technology to help the patient/family and facilitate the supportive role of the diabetes management team may be able to overcome racial disparity in glycemic outcome and improve patient quality of life.
对于 1 型糖尿病 (T1D) 患者来说，实现 HbA1c 水平正常或接近正常的血糖控制对于预防慢性并发症的发生和发展非常重要。尽管已经明确并传播了 HbA1c 管理目标，并且在胰岛素药理学、胰岛素输送系统和血糖监测方面取得了进展，但大多数 T1D 儿童仍无法达到 HbA1c 目标。特别是，非裔美国人更不可能达到 HbA1c 目标，而且 HbA1c 持续高于非西班牙裔白人。泵和其他技术的可用性并没有消除 HbA1c 方面的差异。多种因素在 HbA1c 结果方面的持续种族差异中发挥作用。仔细设计和应用新技术以帮助患者/家庭并促进糖尿病管理团队的支持作用，可能有助于克服血糖结果方面的种族差异，并提高患者的生活质量。
